Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Alimentary Pharmacology & Therapeutics|May 25, 2010
Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's diseaseS B Hanauer, J Panes, J-F Colombel, et al.
Gastroenterology|August 1, 1989
Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control studyB A Lashner, P A Heidenreich, G L Su, et al.
Cancer|November 1, 1981
Disseminated Trichosporon beigelii (cutaneum)C W Yung, S B Hanauer, D Fretzin, et al.
Diseases of the Colon and Rectum|October 1, 1989
Gastric fistulas in Crohn's disease. Report of casesA J Greenstein, D H Present, D B Sachar, et al.
Hepatology (Baltimore, Md.)|January 1, 1985
Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel diseaseJ M Bengoa, S B Hanauer, M D Sitrin, et al.
Gastroenterology|December 2, 1999
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trialE D Ehrenpreis, S V Kane, L B Cohen, et al.
The American Journal of Gastroenterology|January 1, 1989
Cigarette smoking in Crohn's diseaseM D Silverstein, B A Lashner, S B Hanauer, et al.
Digestive Diseases and Sciences|March 1, 1990
Dysplasia and cancer complicating strictures in ulcerative colitisB A Lashner, B C Turner, D G Bostwick, et al.
Gastroenterology|December 2, 1999
Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polypsP H Rubin, S Friedman, N Harpaz, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2010
Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled studyS Schreiber, I C Lawrance, O Ø Thomsen, et al.
Pageof 16